Diligence memo · auto-generated · as of July 2, 2026
EOF Bio LLC
EOF Bio LLC looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
EOF Bio LLC operates in Biotech / Pharma, based in GEORGETOWN.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
EOF Bio LLC has raised $584K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $584K on 2023-06-30.
Most recent recorded round closed around 2023-06-30.
Valuation (modeled)modeled
Provath models EOF Bio LLC at approximately $4.9M (range $319K–$22M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.32× the median modeled value of Pre-Seed Biotech / Pharma companies in 2022–2024 (28 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 3.0 yr ago; this sector typically re-raises about every 15 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 25% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 25% of those peers.
Closest niche peers: Gaingels Oct Bio LLC, Gaingels Alto Pharmacy LLC, Pyros Pharmaceuticals, Inc., Allander Biotechnologies, Inc., CyMon Bio, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.